PRISM BioLab Co.,LTD (206A.T)
JPY 292.0
(-1.68%)
JPY 292.0
(-1.68%)
| Breakdown | 2023 | 2022 |
|---|---|---|
| Revenue | 112.92 Million | 554.39 Million |
| Cost of Revenue | 32.62 Million | 19.25 Million |
| Gross Profit | 80.3 Million | 535.13 Million |
| Operating Expenses | 576.81 Million | 468.45 Million |
| Selling, General and Administrative Expenses | 238.08 Million | - |
| Research and Development Expenses | 338.73 Million | - |
| Other Expenses | - | -1.49 Million |
| Cost and Expenses | 609.79 Million | 487.71 Million |
| Operating Income | -496.86 Million | 66.68 Million |
| Interest Expense | - | - |
| Income Tax Expense | 1.21 Million | 1.19 Million |
| Earnings before Tax | -525.7 Million | 74.15 Million |
| Net Income | -526.91 Million | 72.96 Million |
| Earnings Per Share Basic | -14.90 | - |
| Earnings Per Share Diluted | -14.90 | - |
| Weighted Average Shares Outstanding | 35.35 Million | - |
| Weighted Average Shares Outstanding (Diluted) | 35.35 Million | - |
| Gross Margin | 0.71 | 0.97 |
| EBIT Margin | -4.32 | 0.13 |
| Profit Margin | -4.67 | 0.13 |
| EBITDA | -488.13 Million | 67.89 Million |
| Earnings Before Tax Margin | -4.40 | 0.12 |
| Breakdown | 2024 Q3 | 2023 FY | 2022 FY |
|---|---|---|---|
| Revenue | 99.67 Million | 112.92 Million | 554.39 Million |
| Cost of Revenue | 41.8 Million | 32.62 Million | 19.25 Million |
| Gross Profit | 57.87 Million | 80.3 Million | 535.13 Million |
| Operating Expenses | 266.67 Million | 577.17 Million | 468.45 Million |
| Selling, General and Administrative Expenses | 266.67 Million | - | - |
| Research and Development Expenses | - | - | - |
| Other Expenses | - | 70 Thousand | -1.49 Million |
| Cost and Expenses | 308.47 Million | 609.79 Million | 487.71 Million |
| Operating Income | -208.79 Million | -496.86 Million | 66.68 Million |
| Interest Expense | - | - | - |
| Income Tax Expense | 303 Thousand | 1.21 Million | 1.19 Million |
| Earnings before Tax | -233.19 Million | -525.7 Million | 74.15 Million |
| Net Income | -233.49 Million | -526.91 Million | 72.96 Million |
| Earnings Per Share Basic | -7.45 | - | - |
| Earnings Per Share Diluted | -7.45 | - | - |
| Weighted Average Shares Outstanding | 31.35 Million | - | - |
| Weighted Average Shares Outstanding (Diluted) | 31.35 Million | - | - |
| Gross Margin | 0.58 | 0.71 | 0.97 |
| EBIT Margin | -2.34 | - | - |
| Profit Margin | -2.34 | -4.67 | 0.13 |
| EBITDA | -233.19 Million | - | - |
| Earnings Before Tax Margin | -2.09 | -4.40 | 0.12 |
TALF
BBDC
CSTPF
8622
MGRB
4559